Navigation Links
Sepsis Therapy in Preemies Fails to Boost Survival
Date:1/16/2009

Study suggests future treatments should focus on wider view of antibacterial defenses

FRIDAY, Jan. 16 (HealthDay News) -- Boosting the immune systems of premature babies with blood cell growth factor fails to prevent sepsis or improve survival rates, a new study shows.

Premature babies, especially those with lower than normal birth weight, tend to be prone to infections from low white blood cell counts. Blood growth factors, such as granulocyte-macrophage colony stimulating factor (GM-CSF), increase white blood cell counts and are often used in cancer patients to counter immune suppression caused by chemotherapy.

The London-based study, published in the current issue of The Lancet, found giving GM-CSF to premature babies with low birth weight did increase their white counts but, when compared with preterms who did not receive the treatment, they did not have lower rates of infection or better survival rates.

"We believe that, before embarking on future single-agent clinical trials, we should consider if this is too simplistic an approach to sepsis prevention in the preterm infant, whose immune system appears compromised in many different ways. ... Successful future stratagems will need a wider view of their antibacterial defenses," wrote the authors, lead by Robert Carr of Guy's and St Thomas Hospital NHS Trust in London.

More information

The U.S. National Library of Medicine has more about sepsis.



-- Kevin McKeever



SOURCE: The Lancet, news release, Jan. 15, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Medical Simulation Corporation Introduces Sepsis Quality Initiative Program
2. Educational Drive Cut Death Rate From Sepsis
3. Ashwell receptor reduces mortality during sepsis
4. Customized treatments for sepsis lower treatment time and reduce length of ICU stays
5. Research May Yield New Weapons Against Sepsis
6. Blacks More Likely to Die of Severe Sepsis
7. Scientists Probe Sepsis Deadly Secrets
8. Estonian Cancer Patients Have Access to More Conformal Radiotherapy Treatments for First Time with Unveiling of Advanced Varian Treatment Machine
9. Hispanics Respond Poorly to Standard Hepatitis C Therapy
10. UNC study supports role of circadian clock in response to chemotherapy
11. North Carolina Company Announces First Chronic Pain Control Unit Combining Two Most Used Forms of Electrotherapy For Chronic Pain - Tens & Interferential
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sepsis Therapy in Preemies Fails to Boost Survival 
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: